<DOC>
	<DOCNO>NCT03029624</DOCNO>
	<brief_summary>The study single arm , prospective study safety effectiveness Valencia Technologies eCoin System stimulate tibial nerve treatment patient refractory urgency urinary incontinence .</brief_summary>
	<brief_title>eCoin Tibial Nerve Stimulation OAB</brief_title>
	<detailed_description>This trial single arm , prospective study safety effectiveness eCoin tibial nerve stimulation 25 subject refractory overactive bladder define American Urological Association.. The eCoin neuromodulation device implant subcutaneously right leave leg patient urgency urinary incontinence . After 4 week implant healing period , subject device activate ( turn ON ) . After 3 month device therapy ( occur 4 month post-implant ) , primary endpoint assess . It anticipate subject reach full therapeutic effect approximately 3 month therapy . Subjects follow additional 9 month assess safety maintenance stimulation therapy few session occur time interval .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<criteria>1 . Women men 18 year old . 2 . Diagnosis overactive bladder urgency urinary incontinence mixed urge stress incontinence predominant urgency component , least 6 month ( selfreported ) . 3 . Individual least four urgency incontinence episode threeday void diary least one episode per 24 hour time period 4 . Individual urinary frequency , define average great equal 8 times/24 hour ( ie . total great equal 24 micturition 3 day diary ) 5 . Individual unresponsive , inadequately responsive , intolerant behavioral , rehabilitation , pharmacologic therapy . 6 . Individual able give write , informed consent . 7 . Individual mentally competent able understand study requirement . 8 . Individual willing able complete 3day void diary quality life questionnaire . 9 . Individual without pharmacological treatment overactive bladder ( antimuscarinics beta3 agonist ) 2 week prior screen . 10 . The individual demonstrates positive nerve integrity test . 1 . Individual predominantly stress urinary incontinence 2 . Individual clinically significant bladder outlet obstruction . 3 . Individual clinically significant pelvic organ prolapse . 4 . Individual abnormal post void residual ( i.e. , great 150 cc ) . 5 . Individual clinically significant urethral stricture disease bladder neck contracture 6 . Individual active urinary tract infection time enrollment . 7 . Individual recurrent urinary tract infection define 4 UTI 's per year . 8 . Individual morbid obesity . 9 . Individual positive urine cytology diagnosis bladder prostate cancer . 10 . Individual neurogenic bladder dysfunction . 11 . Individual take alphablocker benign prostatic hyperplasia . 12 . Individual pregnant intend become pregnant study . 13 . Patient breast feed less 9month postpartum . 14 . Individual presence urinary fistula , bladder stone , interstitial cystitis . 15 . Individual uncontrolled diabetes mellitus . 16 . Individual cardiac pacemaker implant defibrillator . 17 . Individual previously treat sacral nerve stimulation . 18 . Individual treat onabotulinumtoxinA previous 9 month prior enrollment . 19 . Individual treat percutaneous tibial nerve stimulation within previous 12 week prior enrollment . 20 . Individual require regular Magnetic Resonance Imaging health care condition . ( ASK ) 21 . Individual clot bleed disorder ; antiplatelet anticoagulant therapy may continue hold discretion investigator 22 . Individual clinically significant peripheral neuropathy . 23 . Individual neutropenic immunocompromised .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>